|
|
|
|
|
|
Device-Based Glaucoma Therapy: A client engaged Health Advances to determine the market size and segmentation for a novel device to treat
glaucoma. Health Advances quantified the economics of the entire range of glaucoma diagnostics and treatments from the perspectives of payers, doctors,
patients, and facilities.
Diagnostic for Diabetic Retinopathy: Health Advances worked for a venture-backed company to assess the state-by-state reimbursement potential
for a novel diagnostic with a complex revenue generation model. The Health Advances' team developed the investor road show characterizing the opportunity
and estimating market potential.
Novel Therapy for Improving Night Vision: Health Advances tested product concepts for a novel therapy for night vision with thought leaders
and practitioners, including ophthalmologists and optometrists. A detailed model projected the potential market size, considering likely penetration into
different patient segments and pricing potential for the therapy in the US market.
Cataract and Refractive Surgery Devices: Health Advances conducted due diligence for a private equity investor on a manufacturer of equipment
and disposables used in cataract and refractive procedures. The Health Advances' team also investigated the competitive landscape and emerging technologies
through secondary research and primary interviews with ophthalmologists in the US and Germany.
Amblyopia Treatment: Health Advances conducted consumer research with amblyopia patients to assess willingness to self pay for therapy.
The market potential was determined considering patients' preferred treatment regimen and pricing threshold among various patient segments for a
computer-based treatment for amblyopia.
Ear Infection (Otitis Media): Many young children experience six or more ear infections per year, and these infections, commonly treated
with inexpensive antibiotics, place these young patients at risk for hearing loss and the development of antibiotic resistance. Our client identified a
novel, non-vaccine approach to the prevention of ear infections. Health Advances was asked to investigate the potential to change pediatricians' existing
treatment paradigm, to determine whether physicians could select patients for treatment before patients entered a cycle of infections, and to project how
that would translate into market potential. We went on to assist the client with a strategy for positioning the product and identifying potential commercialization partners.
|
|
 |
|
|
|
|
